The FDA’s decision to extend the labeled duration of faricimab use in RVO beyond 6 months primarily reflects accumulated evidence supporting its continued efficacy and safety over longer treatment ...
The FDA approved an updated label for Vabysmo for the treatment of macular edema following retinal vein occlusion beyond 6 ...
WASHINGTON— Cyclophotocoagulation, a safe and effective procedure, should be considered by ophthalmologists more often for ...
As expectations for refractive cataract surgery continue to rise, preoperative ocular surface optimization remains essential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results